Getting to Grip with Non-Invasive Tests to Assess Liver Fibrosis & Patient Eligibility for Novel MASH Therapies

Nov 10 2025
Convention Center: Room 150, Level 1
12:30 PM - 2:00 PM

World Class Speakers

Quentin M Anstee, MBBS, PhD, FRCP
Industry Presenter

Quentin M Anstee, MBBS, PhD, FRCP

Newcastle University, UK
Meena B Bansal, MD, FAASLD
Industry Presenter

Meena B Bansal, MD, FAASLD

Icahn School of Medicine at Mount Sinai (ISMMS)
Arun J. Sanyal, MD, FAASLD
Industry Presenter

Arun J. Sanyal, MD, FAASLD

Virginia Commonwealth University

Description

Join us for a symposium on liver fibrosis designed to encourage the exchange of ideas between leaders in the field and attendees.


Supported by: Siemens Healthineers

Organized by: Medscape Education


For more information and to register, visit: https://events.medscapelive.org/website/89041/

Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Journey Maps

Objectives

  • Have increased knowledge regarding the: Cut-off values for use of noninvasive tests to assess liver fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Clinical data on novel therapies for MASH.
  • Have greater competence related to evaluating liver fibrosis in patients with MASH
  • Demonstrate greater confidence in their ability to assess for liver fibrosis using noninvasive tests